According to Glenmark Pharmaceuticals
's latest financial reports the company has C$1.41 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-03-31 | $C$1.27 B | -21.36% |
2023-03-31 | $C$1.62 B | 4.3% |
2022-03-31 | $C$1.55 B | 27.99% |
2021-03-31 | $C$1.21 B | 6.35% |
2020-03-31 | $C$1.14 B | 5.94% |
2019-03-31 | $C$1.07 B | -2.77% |
2018-03-31 | $C$1.10 B | 9.03% |
2017-03-31 | $C$1.01 B | 21.74% |
2016-03-31 | $C$0.83 B | 37.26% |
2015-03-31 | $C$0.60 B | 9.92% |
2014-03-31 | $C$0.55 B | 5.92% |
2013-03-31 | $C$0.52 B | 9.61% |
2012-03-31 | $C$0.47 B | 6.03% |
2011-03-31 | $C$0.44 B | -16.28% |
2010-03-31 | $C$0.53 B | 34.92% |
2009-03-31 | $C$0.39 B | 1.89% |
2008-03-31 | $C$0.39 B | 112.22% |
2007-03-31 | $C$0.18 B | 78.56% |
2006-03-31 | $C$0.10 B | 12.95% |
2005-03-31 | $C$91.24 M | 28.59% |
2004-03-31 | $C$70.95 M |